← Open Payments lookup

IRINA KIBLITSKY: Open Payments

NPI 1215112719 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,974 in 162 payments from 21 companies in 2025. Trend: 2023 $2,617 · 2024 $4,478 · 2025 $4,974

Food & beverage: $4,754Education: $219
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.31$1,088
Teva Pharmaceuticals USA, Inc.22$732
ABBVIE INC.16$521
Lundbeck LLC18$492
Alkermes, Inc.13$370
Vanda Pharmaceuticals Inc.13$290
Neurocrine BioSciences, Inc.7$238
Janssen Pharmaceuticals, Inc6$215
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$189
Axsome Therapeutics, Inc.10$184

Products named: REXULTI, VRAYLAR, AUSTEDO XR, ABILIFY ASIMTUFII, LYBALVI, FANAPT, INGREZZA, CAPLYTA.

Industry payments across NY — which companies pay providers there.